No abstract available
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Busulfan / administration & dosage
-
Carmustine / administration & dosage
-
Combined Modality Therapy
-
Cyclophosphamide / administration & dosage
-
Cytarabine / administration & dosage
-
Doxorubicin / administration & dosage
-
Drug Combinations / administration & dosage
-
Drug Evaluation
-
Female
-
Humans
-
Leukemia, Myeloid, Acute / drug therapy*
-
Leukemia, Myeloid, Acute / radiotherapy
-
Male
-
Meningeal Neoplasms / prevention & control
-
Mercaptopurine / administration & dosage
-
Methotrexate / administration & dosage
-
Middle Aged
-
Mitoguazone / administration & dosage
-
Prednisone / administration & dosage
-
Thioguanine / administration & dosage
-
Vincristine / administration & dosage
Substances
-
Drug Combinations
-
Cytarabine
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Mercaptopurine
-
Thioguanine
-
Busulfan
-
Mitoguazone
-
Carmustine
-
Prednisone
-
Methotrexate
Supplementary concepts
-
COAP protocol
-
POMP protocol